Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.

MLA

Faisal, Nabiha, et al. “Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.” Experimental & Clinical Transplantation, vol. 17, no. 1, Feb. 2019, pp. 59–63. EBSCOhost, https://doi.org/10.6002/ect.2017.0201.

APA

Faisal, N., Bilodeau, M., Aljudaibi, B., Hirch, G., Yoshida, E. M., Hussaini, T., Ghali, M. P., Congly, S. E., Ma, M. M., & Lilly, L. B. (2019). Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study. Experimental & Clinical Transplantation, 17(1), 59–63. https://doi.org/10.6002/ect.2017.0201

Chicago

Faisal, Nabiha, Marc Bilodeau, Bandar Aljudaibi, Geri Hirch, Eric M. Yoshida, Trana Hussaini, Maged P. Ghali, Stephen E. Congly, Mang M. Ma, and Leslie B. Lilly. 2019. “Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.” Experimental & Clinical Transplantation 17 (1): 59–63. doi:10.6002/ect.2017.0201.